These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 33739229)

  • 41. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.
    Leavitt A; Chmelnitsky I; Ofek I; Carmeli Y; Navon-Venezia S
    J Antimicrob Chemother; 2010 Feb; 65(2):243-8. PubMed ID: 19939824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
    Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
    Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
    Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissemination of Klebsiella pneumoniae ST11 isolates with carbapenem resistance in integrated and emergency intensive care units in a Chinese tertiary hospital.
    Yu F; Hu L; Zhong Q; Hang Y; Liu Y; Hu X; Ding H; Chen Y; Xu X; Fang X; Yu F
    J Med Microbiol; 2019 Jun; 68(6):882-889. PubMed ID: 31050634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
    Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
    J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Prevalence and Geographical Variations of Carbapenem-Resistant Klebsiella pneumoniae ST15 Isolates in a Tertiary Hospital in Ningbo, China.
    Gao H; Tu Y; Li Q; Wu Q
    Med Sci Monit; 2024 Jun; 30():e943596. PubMed ID: 38831571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular and Epidemiological Characteristics of Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates in Japan.
    Yonekawa S; Mizuno T; Nakano R; Nakano A; Suzuki Y; Asada T; Ishii A; Kakuta N; Tsubaki K; Mizuno S; Ogawa M; Yano H; Kasahara K; Mikasa K
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
    Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
    Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular epidemiology and drug resistant mechanism in carbapenem-resistant Klebsiella pneumoniae isolated from pediatric patients in Shanghai, China.
    Zhang X; Chen D; Xu G; Huang W; Wang X
    PLoS One; 2018; 13(3):e0194000. PubMed ID: 29558475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China.
    Jiang Y; Shen P; Wei Z; Liu L; He F; Shi K; Wang Y; Wang H; Yu Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):66-70. PubMed ID: 25450805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy.
    Loconsole D; Accogli M; De Robertis AL; Capozzi L; Bianco A; Morea A; Mallamaci R; Quarto M; Parisi A; Chironna M
    Ann Clin Microbiol Antimicrob; 2020 Jun; 19(1):24. PubMed ID: 32487201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant
    Hu Y; Liu C; Shen Z; Zhou H; Cao J; Chen S; Lv H; Zhou M; Wang Q; Sun L; Sun Q; Hu F; Wang Y; Zhang R
    Emerg Microbes Infect; 2020 Dec; 9(1):1771-1779. PubMed ID: 32689907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis.
    Lübbert C; Becker-Rux D; Rodloff AC; Laudi S; Busch T; Bartels M; Kaisers UX
    Infection; 2014 Apr; 42(2):309-16. PubMed ID: 24217959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and mechanisms of fosfomycin resistance among KPC-producing Klebsiella pneumoniae clinical isolates in China.
    Huang L; Cao M; Hu Y; Zhang R; Xiao Y; Chen G
    Int J Antimicrob Agents; 2021 Jan; 57(1):106226. PubMed ID: 33212165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
    Jia P; Jia X; Zhu Y; Liu X; Yu W; Li R; Li X; Kang M; Xu Y; Yang Q
    Microbiol Spectr; 2022 Oct; 10(5):e0084222. PubMed ID: 35993711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients.
    Shimasaki T; Seekatz A; Bassis C; Rhee Y; Yelin RD; Fogg L; Dangana T; Cisneros EC; Weinstein RA; Okamoto K; Lolans K; Schoeny M; Lin MY; Moore NM; Young VB; Hayden MK;
    Clin Infect Dis; 2019 May; 68(12):2053-2059. PubMed ID: 30239622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital.
    Stillwell T; Green M; Barbadora K; Ferrelli JG; Roberts TL; Weissman SJ; Nowalk A
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):330-8. PubMed ID: 26582872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics.
    Su S; Zhang J; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Li C; Zhang X
    BMC Infect Dis; 2020 Jul; 20(1):472. PubMed ID: 32616018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in south of Italy.
    Fasciana T; Gentile B; Aquilina M; Ciammaruconi A; Mascarella C; Anselmo A; Fortunato A; Fillo S; Petralito G; Lista F; Giammanco A
    BMC Infect Dis; 2019 Nov; 19(1):928. PubMed ID: 31684890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.
    Orsi GB; Bencardino A; Vena A; Carattoli A; Venditti C; Falcone M; Giordano A; Venditti M
    Infection; 2013 Feb; 41(1):61-7. PubMed ID: 23070604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.